Search by Drug Name or NDC

    NDC 65219-0380-30 Allopurinol 500 mg/25mL Details

    Allopurinol 500 mg/25mL

    Allopurinol is a INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Fresenius Kabi USA, LLC. The primary component is ALLOPURINOL SODIUM.

    Product Information

    NDC 65219-0380
    Product ID 65219-380_2d2f4a09-b8bd-47ff-87db-a615efc34c4c
    Associated GPIs 68000010102120
    GCN Sequence Number 042808
    GCN Sequence Number Description allopurinol sodium VIAL 500 MG INTRAVEN
    HIC3 C7A
    HIC3 Description HYPERURICEMIA TX - XANTHINE OXIDASE INHIBITORS
    GCN 93465
    HICL Sequence Number 020274
    HICL Sequence Number Description ALLOPURINOL SODIUM
    Brand/Generic Generic
    Proprietary Name Allopurinol
    Proprietary Name Suffix n/a
    Non-Proprietary Name Allopurinol
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
    Route INTRAVENOUS
    Active Ingredient Strength 500
    Active Ingredient Units mg/25mL
    Substance Name ALLOPURINOL SODIUM
    Labeler Name Fresenius Kabi USA, LLC
    Pharmaceutical Class Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA212363
    Listing Certified Through 2024-12-31

    Package

    NDC 65219-0380-30 (65219038030)

    NDC Package Code 65219-380-30
    Billing NDC 65219038030
    Package 1 VIAL, GLASS in 1 CARTON (65219-380-30) / 25 mL in 1 VIAL, GLASS
    Marketing Start Date 2022-03-14
    NDC Exclude Flag N
    Pricing Information N/A